Document:

Exhibit 10.3

 

	
  Notice
  of Award of Restricted Stock and 

  	
  Staples, Inc.

  
	
  Restricted
  Stock Award Agreement

  	
  Employer ID:
  04-2896127

  
	
   

  	
  500 Staples
  Drive

  
	
   

  	
  Framingham, MA
  01702

  

 

	
  «FirstName» «LastName»

  	
   

  	
  ACCOUNT ID:

  	
   

  	
  «AccountID»

  
	
  «Address1»

  	
   

  	
   

  	
   

  	
   

  
	
  «Address2»

  	
   

  	
   

  	
   

  	
   

  
	
  «City», «State» «Zip»

  	
   

  	
   

  	
   

  	
   

  
	
  «Country»

  	
   

  	
   

  	
   

  	
   

  

 

In consideration
of services rendered to Staples, Inc., you have been awarded shares of
Staples, Inc. Common Stock under Staples, Inc.’s Restricted Stock
program as follows:

 

	
  Restricted Stock
  Award No.:

  	
   

  	
  «GrantNumber»

  
	
  Stock Plan:

  	
   

  	
  2004RS

  
	
  Date of Award:

  	
   

  	
   

  
	
  Total Number of
  Shares:

  	
   

  	
  «SharesGranted»

  
	
  Fair Market
  Value per Share:

  	
   

  	
  «FairValue»

  
	
  Total Value of
  Shares Granted:

  	
   

  	
   

  
	
  Vesting Date:

  	
   

  	
   

  

 

By your acceptance
of this Restricted Stock Award, you acknowledge that this award is granted
under and governed by the terms and conditions of Staples, Inc.’s Amended
and Restated 2004 Stock Incentive Plan (as further amended or restated from
time to time) and by the terms and conditions of Staples, Inc.’s
Restricted Stock Award Agreement which is attached hereto.

 

	
   

  	
  Staples, Inc.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Ronald L.
  Sargent 

  
	
   

  	
  Chairman and
  Chief Executive Officer

  

 

 

STAPLES, INC.

RESTRICTED
STOCK AWARD AGREEMENT

(DIRECTORS)

 

1.  Award.  In consideration of services rendered,
Staples, Inc., a Delaware corporation (“Staples”), hereby awards to the
Director named in the Notice of Award, pursuant to Staples’ Amended and
Restated 2004 Stock Incentive Plan (the “Plan”), the Total Number of Shares of
Common Stock of Staples stated in the Notice of Award (the “Shares”) subject to
the terms and conditions of this Restricted Stock Award Agreement and the Plan.
Except where the context otherwise requires, the term “Staples” shall include
any parent and all present and future subsidiaries of Staples as defined in
Sections 424(e) and 424(f) of the Internal Revenue Code of 1986, as
amended or replaced from time to time (the “Code”).

 

2. Transferability of Shares.  During the Holding Period described below,
the Shares may not be sold, assigned, transferred, pledged, hypothecated or
otherwise disposed of (whether by operation of law or otherwise) nor shall
Shares be subject to execution, attachment or similar process, except that the
Shares may be transferred by will or the laws of descent and distribution or,
upon notice to Staples, for estate planning purposes to entities that are
beneficially owned entirely by family members. 
All transferees of the Shares must agree to be governed by all of the
terms and conditions of this Agreement. 
Upon any sale, transfer, assignment, pledge, hypothecation or other
disposition, or any attempt to sell, assign, transfer, pledge, hypothecate or
otherwise dispose, of the Shares contrary to the provisions hereof, or upon the
levy of any execution, attachment or similar process upon the Shares or such
rights, the Shares shall, at the election of Staples, be deemed repurchased by
Staples at a repurchase price of zero and all rights with respect to the Shares
shall be forfeited to Staples.  In addition,
Staples may seek any other legal or equitable remedies available to it,
including rights of specific performance.  
Staples may refuse to recognize as a shareholder of Staples any
purported transferee of or holder of any rights with respect to the Shares and
may retain and/or recover all dividends, dividend equivalents and other
distributions payable or paid with respect to such Shares.

 

3.  Holding Period.  Except as otherwise provided in this
Agreement, the Holding Period shall begin on the Date of Award and end when the
Director ceases to be an Eligible Director (as defined below).

 

4.  Vesting Date.

 

(a)  Continuous Relationship with Staples
Required.  For purposes of
this Agreement, an “Eligible Director” is an individual that is, and has has
been at all times since the Date of Award, a director of Staples.

 

(b)   Vesting;
Termination of Relationship with Staples.  If the Director ceases to be an Eligible
Director for any reason before the Vesting Date, then, except as provided in
paragraph (c) below, the Shares shall be deemed repurchased by Staples at
a repurchase price of zero and ownership of all right, title and interest in
and to the Shares shall be forfeited and revert to Staples on the date such
Director ceases to be an Eligible Director. 
If the Director is an Eligible Director on the Vesting Date, the Shares
shall no longer be subject to repurchase/forfeiture as provided in this Section 4.  If the Director is on an approved leave of
absence, then the Shares shall not be forfeited, and the Holding Period shall
not terminate, as a result of such leave of absence, unless and until the
Director’s position as a director is ultimately terminated.

 

(c)  Vesting Upon Death or Disability or
Retirement.  If the
Director (i) dies; (ii) becomes disabled (within the meaning of Section 22(e)(3) of
the Code); or (iii) terminates his or her position as a director of
Staples upon or after reaching age 72, in each case prior to the Vesting
Date,  while he or she is an Eligible
Director, then the Shares shall no longer be subject to repurchase/forfeiture
as provided in this Section 4 and the Holding Period shall terminate.  In addition and subject to Section 11 of
this Agreement, if the Director reaches age 72 before the Vesting Date while he
or she is an Eligible Director, a number of Shares that is sufficient to
satisfy the Eligible Director’s federal, state or local income and tax
obligations with respect to the Shares that are triggered by such event shall
no longer be subject to repurchase/forfeiture as provided in this Section 4,
and the Holding Period with respect to such number of Shares shall terminate.

 

(d)  Repurchase/Forfeiture.  Upon repurchase/forfeiture of the Shares for
any reason hereunder, the Director shall cease to have any rights or privileges
as a stockholder of Staples with respect to the Shares repurchased/forfeited
and such Shares shall again be available for subsequent option grants or awards
under the Plan.

 

 

5.  Delivery of Shares.  Staples shall, upon the Date of Award, effect
issuance of the Shares by registering the Shares in book entry form with
Staples’ transfer agent in the name of the Director.   No certificate(s) representing all or a
part of the Shares that have not been repurchased/forfeited shall be issued
until the end of the Holding Period.

 

6.  No Rights to Continue as a
Director.  Nothing
contained in the Plan or this Agreement shall be construed or deemed by any
person under any circumstances to bind Staples to continue the relationship of
the Director with Staples for the period before or after the Vesting Date.

 

7.  Rights as a Shareholder.  Except as otherwise provided herein, the
Director shall have all rights as a shareholder with respect to the Shares
including, without limitation, any rights to receive dividends or other
distributions with respect to the Shares and to vote the Shares and act in
respect of the Shares at any meeting of shareholders.

 

8.  Adjustment Provisions.

 

(a)  General.   In the event of any recapitalization,
reclassification of shares, combination of shares, stock dividend, stock split,
reverse stock split, spin-off or other similar change in capitalization or
event or any distribution to holders of Common Stock other than an ordinary
cash dividend, the Director shall, with respect to the Shares, be entitled to
the rights and benefits, and be subject to the limitations, set forth in Section 9
of the Plan.

 

(b)  Board  Authority
to Make Adjustments.  Any
adjustments under this Section 8 will be made by the Board of Directors,
whose determination as to what adjustments, if any, will be made and the extent
thereof will be final, binding and conclusive. 
No fractional shares will be issued with respect to Shares on account of
any such adjustments.

 

9.  Mergers, Consolidations,
Distributions, Liquidations, Etc.  In the event of a merger or consolidation or
any share exchange transaction in which outstanding shares of Common Stock are
exchanged for securities, cash or other property of any other corporation or
business entity, or in the event of a liquidation of Staples, the Director
shall, with respect to this Agreement, be entitled to the rights and benefits,
and be subject to the limitations, set forth in Section 9 of the Plan.

 

10.  Vesting Following a Change
in Control.

 

(a)  Definitions.  For purposes of this Agreement, the following
terms shall have the following meanings:

 

(i)  A “Change in Control” shall be deemed to have occurred if (A) any
“person”, as such term is used in Sections 13(d) and 14(d) of the
Securities Exchange Act of 1934 (the “Exchange Act”) (other than Staples, any
trustee or other fiduciary holding securities under an employee benefit plan of
Staples, or any corporation owned directly or indirectly by the stockholders of
Staples in substantially the same proportion as their ownership of stock of
Staples), is or becomes the “beneficial owner” (as defined in Rule 13d-3
under the Exchange Act), directly or indirectly, of securities of Staples
representing 30% or more of the combined voting power of Staples’ then
outstanding securities (other than pursuant to a merger or consolidation
described in clause (1) or (2) of subsection (C) below); (B) individuals
who, as of the date hereof, constitute the Board of Directors of Staples (as of
the date hereof, the “Incumbent Board”) cease for any reason to constitute at
least a majority of the Board of Directors, provided that any person becoming a
director subsequent to the date hereof whose election, or nomination for
election by Staples’ stockholders, was approved by a vote of at least a
majority of the directors then comprising the Incumbent Board (other than an
election or nomination of an individual whose initial assumption of office is
in connection with an actual or threatened election contest relating to the
election of the directors of Staples, as such terms are used in Regulation 14A
under the Exchange Act) shall be, for purposes of this Agreement, considered as
though such person were a member of the Incumbent Board; (C) the
stockholders of Staples approve a merger or consolidation of Staples with any
other corporation, and such merger or consolidation is consummated, other than (1) a
merger or consolidation which would result in the voting securities of Staples
outstanding immediately prior thereto continuing to represent (either by
remaining outstanding or by being converted into voting securities of the
surviving entity) more than 75% of the combined voting power of the voting
securities of Staples or such surviving entity outstanding immediately after
such merger or consolidation, or (2) a merger or consolidation effected to
implement a 

 

 

recapitalization
of Staples (or similar transaction) in which no “person” (as defined above)
acquires more than 30% of the combined voting power of Staples’ then
outstanding securities; or (D) the stockholders of Staples approve an
agreement for the sale or disposition by Staples of all or substantially all of
Staples’ assets, and such sale or disposition is consummated.

 

(ii) “Surviving Corporation” shall mean (x) in the case of a
Change in Control pursuant to clause (A) or clause (B) of Section 10(a)(i),
Staples; (y) in the case of a Change in Control pursuant to clause (C) of
Section 10(a)(i), the surviving or resulting corporation in such merger or
consolidation; and (z) in the case of a Change in Control pursuant to
Clause (D) of Section 10(a)(i), the entity acquiring the majority of
the assets being sold or disposed of by Staples.

 

(b)  Effect of Change of Control.
Notwithstanding the provisions of Sections 3 and 4, if a Change in Control of
Staples occurs, the Shares shall no longer be subject to repurchase/forfeiture
as provided in Section 4 and the Holding Period shall terminate.

 

11.  Withholding Taxes.  Notwithstanding anything to the contrary in
this Agreement, any provisions providing that the Shares shall no longer be
subject to repurchase/forfeiture or that the Holding Period shall terminate
shall be subject to the Director’s satisfaction of all applicable federal,
state and local income tax withholding requirements.

 

12.  Miscellaneous.

 

(a)  Except as provided herein, this Agreement may not be amended
or otherwise modified unless evidenced in writing and signed by Staples and the
Director unless the Board of Directors determines that the amendment or
modification, taking into account any related action, would not materially and adversely
affect the Director.

 

(b)  All notices under this Agreement shall be mailed or delivered
by hand to Staples at its main office, Attn: Secretary, and to the Director to
his/her last known address on the records of Staples or at such other address as
may be designated in writing by either of the parties to one another.

 

(c)  This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware.Exhibit 10.1

 

SECOND AMENDMENT TO PATENT TRANSFER AGREEMENT

 

THIS IS A SECOND AMENDMENT, dated as of May 15, 2008, to that
certain PATENT TRANSFER AGREEMENT dated as of May 11, 2005 (the “Patent
Transfer Agreement”) by and between Bayer Schering Pharma AG, a German
corporation having its principal place of business in Müllerstraße 178, 13353
Berlin, Germany (hereinafter referred to as “BSP”) and Acusphere, Inc., a
Delaware corporation having its place of business at 500 Arsenal Street,
Watertown, MA 02472, USA (hereinafter referred to as “Acusphere”)

 

WHEREAS, BSP (formerly acting under the name Schering
Aktiengesellschaft) and Acusphere entered into the Patent Transfer Agreement on
May 11, 2005, pursuant to which certain patent rights were transferred
from BSP to Acusphere;

 

WHEREAS, under an Amendment to the Patent Transfer Agreement dated April 27,
2007 (the “First Amendment”) Acusphere will be obligated to make a payment of
$1,000,000 to BSP on or before fifteen days after May 11, 2008 and a
payment of another $1,000,000 to BSP on or before fifteen days after May 11,
2009;

 

WHEREAS, Acusphere wishes to defer payment of such May 11, 2008
payment and BSP is willing to agree to a deferral on the terms set forth
herein;

 

NOW, THEREFORE, in consideration of the mutual covenants contained
herein, the parties hereto agree as follows:

 

1.               Notwithstanding
anything to the contrary contained in the First Amendment, rather than the
second $2,000,000 payment payable under Section 1.b and 1.c of the First
Amendment, Acusphere shall instead pay BSP a total of $2,000,000 as follows:

 

a.               $200,000 on or
before fifteen days after the execution of this Amendment;

 

b.              $1,800,000 on or
before fifteen days after May 11, 2009; and

 

 

2.               In all other
respects, the Patent Transfer Agreement shall remain in effect as executed.

 

IN WITNESS WHEREOF, the parties have executed this Amendment to Patent
Transfer Agreement as of the date first above written.

 

 

ACUSPHERE, INC.

 

 

	
  BY

  	
  /s/ Sherri C. Oberg

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  BAYER SCHERING PHARMA AG

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  BY

  	
  /s/ Dr. Hans Maier

  	
   

  	
  /s/ Dr. Ulrich Koch

  
	
   

  	
  Dr. Hans Maier

  	
   

  	
  Dr. Ulrich Koch

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]